Literature DB >> 12447004

Use of near-infrared reflection spectroscopy to study the effects of X-ray contrast media on renal tolerance in rats: effects of a prostacyclin analogue and of phosphodiesterase inhibitors.

W Krause1, P Muschick, U Krüger.   

Abstract

RATIONALE AND
OBJECTIVES: Use of near-infrared reflection spectroscopy (NIR-RS) as a new model to assess renal tolerance of contrast agents and determination of the effects of a prostacyclin analogue and of two phosphodiesterase inhibitors on renal tolerance.
MATERIALS AND METHODS: NIR-RS was used to measure total hemoglobin, oxygenated hemoglobin and tissue oxygen saturation in the renal cortex of rats and the effect of diatrizoate, iopromide and iotrolan injected at 1 g iodine/kg alone or together with the prostacyclin derivative, iloprost, or the phosphodiesterase inhibitors, rolipram and mesopram, on these parameters.
RESULTS: Injection of the contrast media alone resulted in a 10% to 35% depression of total hemoglobin, oxygenated hemoglobin, and tissue oxygen saturation approximately 40 to 100 seconds after administration, whereas saline showed no effect and mannitol solution only a minor effect. Coadministration of iloprost or pretreatment with the phosphodiesterase inhibitors, rolipram or mesopram, significantly attenuated the contrast media-induced effects.
CONCLUSION: NIR-RS might be useful for the determination of contrast media-induced side effects. Stable prostacyclin analogues or phosphodiesterase inhibitors have the potential to mitigate these side effects.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12447004     DOI: 10.1097/00004424-200212000-00010

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  3 in total

1.  Detailing renal hemodynamics and oxygenation in rats by a combined near-infrared spectroscopy and invasive probe approach.

Authors:  Dirk Grosenick; Kathleen Cantow; Karen Arakelyan; Heidrun Wabnitz; Bert Flemming; Angela Skalweit; Mechthild Ladwig; Rainer Macdonald; Thoralf Niendorf; Erdmann Seeliger
Journal:  Biomed Opt Express       Date:  2015-01-06       Impact factor: 3.732

2.  Iloprost for prevention of contrast-mediated nephropathy in high-risk patients undergoing a coronary procedure. Results of a randomized pilot study.

Authors:  K Spargias; E Adreanides; G Giamouzis; S Karagiannis; A Gouziouta; A Manginas; V Voudris; G Pavlides; D V Cokkinos
Journal:  Eur J Clin Pharmacol       Date:  2006-07-11       Impact factor: 2.953

Review 3.  Pharmacological strategies to prevent contrast-induced acute kidney injury.

Authors:  Pattharawin Pattharanitima; Adis Tasanarong
Journal:  Biomed Res Int       Date:  2014-02-26       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.